Prevalence of Homologous Recombination Pathway Gene Mutations in Melanoma: Rationale for a New Targeted Therapeutic Approach.
Kim KB, Soroceanu L, de Semir D, Millis SZ, Ross J, Vosoughi E, Dar AA, Nosrati M, Desprez PY, Ice R, Chen M, Chetal K, Bhattacharjee A, Moretto J, Leong SP, Singer MI, Parrett BM, Minor DR, McAllister S, Miller JR 3rd, Salomonis N, Kashani-Sabet M.
Kim KB, et al. Among authors: minor dr.
J Invest Dermatol. 2021 Aug;141(8):2028-2036.e2. doi: 10.1016/j.jid.2021.01.024. Epub 2021 Feb 19.
J Invest Dermatol. 2021.
PMID: 33610559
Free article.